1. United States Pharmacopeia and National Formulary USP 29-NF 24. The United States Pharmacopeial Convention, Inc., Rockville, MD, 2007.
2. A. S. Hussain. Quality by design and risk based regulatory scrutiny: connecting the dots. Presentation at AAPS 39th Annual Pharmaceutical Technologies Conference at Arden House, Harriman, NY, Jan. 25–30 (2004).
3. L. Buhse. Measuring and Managing Method Variability. CDER Advisory Committee for Pharmaceutical Science, October 25, 2005, Rockville, MD, 1:184–219 (2005).
4. S. A. Qureshi. A new crescent-shaped spindle for drug dissolution testing-but why a new spindle? Dissolution Technol. 11:13–18 (2004).
5. F. J. Muzzio and P. Armenante. Action plan for the development of scientifically based bioavailability and dissolution testing systems. Presented at Drug Dissolution and Release Research Program Meeting, Nov. 17, 2005, Piscataway, NJ (Rutgers Univ.), pp. 1–10.